FDA-approved non-nucleoside reverse transcriptase inhibitor.
A drug that inhibits an enzyme used by HIV called "reverse transcriptase." Nevirapine belongs to a class of drugs called NNRTIs ( see entry), and is taken twice daily. Side effects may include fever, rash, and increased liver enzymes. NIAID: The National Institute of Allergy and Infectious Diseases. (US) Night Sweats: Extreme sweating during sleep. Although they can occur with other conditions, night sweats are also a symptom of HIV disease.
a non-nucleoside reverse transcriptase inhibitor (trade name Viramune) used to treat AIDS and HIV
A drug prescribed for use in combination with other anti-HIV drugs. Nevirapine can cause a severe rash in some patients. Reports have also associated nevirapine with hepatotoxicity, a condition which can result in liver damage and death.
a non-nucleoside reverse transcriptase inhibitor drug approved for the treatment of HIV disease. Nevirapine blocks HIV replication by binding to the reverse transcriptase enzyme. Side effects include rash and liver toxicity.
Boehringer Ingelheim's NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI). Nevirapine is FDA-approved for treatment of HIV-infected adults in combination with NUCLEOSIDE ANALOGS. Possible SIDE EFFECTS include severe rash, fever and liver impairment. Nevirapine interacts with many other drugs.
non-nucleoside reverse transcriptase inhibitor first approved by FDA in 1996 and used in combination with antiretroviral agents for the treatment of HIV-1 infection in adults and children 2 months of age or older. Also called Viramune.
A non-nucleoside reverse transcriptase inhibitor (NNRTI), FDA approved for treatment of HIV-infected adults in combination with nucleoside analogues. The drug is effective in preventing HIV transmission from mothers to infants and is widely used in developing countries because of ease of use and low cost; Viramune (trade name) See Viramune.
Non-nucleoside reverse transcriptase inhibitor used in combination with antiretroviral agents for the treatment of HIV; also known as NVP. Generic name for Viramune®.
Nevirapine, also marketed under the trade name Viramune® (Boehringer Ingelheim), is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.
